About the Study
Vitiligo is a disease that causes the loss of skin color in blotches. Vitiligo can affect the skin on any part of the body and may also affect hair color.
Vitiligo symptoms include patchy loss of skin color, premature whitening or graying of the hair on your scalp, eyelashes, eyebrows or beard, loss of color in the tissues inside your mouth and loss or change of color of the inner eye. Vitiligo can start at any age, but often appears before age 20.
Right now, dermatologists at Oregon Medical Research Center are accepting teen and adult participants for a new clinical research study. The study is for an investigational topical medication for vitiligo.
If you are age 12 or older, and have patches of vitiligo on both your face and body, you may qualify for a new clinical research study. By joining the study you will receive:
- Evaluations of your vitiligo by our dermatologists
- Study-related care and medication at no cost (you do not need insurance to participate, but you will need to attend up to 13 scheduled visits to our office during a one-year period)
- Reimbursement for time and travel to attend study visits
What is the purpose of a clinical study?
Clinical studies (also called clinical trials) are used to learn about the safety and the effectiveness of possible new medications. Although there are many types of clinical trials, all must conform to strict rules set by the U.S. Food and Drug Administration (FDA). These rules help protect the rights and the safety of those who volunteer to take part in clinical trials.
Will I have to pay for anything if I participate?
If you qualify and choose to participate, you will receive study-related care (such as study medications and visits to our office) at no cost to you. You will also be reimbursed $75.00 for each study visit for your time and travel.
How long does the study last?
If you join the study, your participation will last up to approximately one year and require up to 13 scheduled visits to our office near Washington Square, at the Greenburg Road exit, just off Highway 217. These visits are an important part of the study, as they allow your study doctor to closely monitor your progress.
Does this study have a placebo?
Most clinical studies have a control group who do not receive medication during the study, or for a period of time during the study. This study has an inactive placebo (1 in 3 may receive the placebo), but at week 24 participants on placebo may be transitioned to the study medication.
What if I join the study and decide I do not want to participate anymore?
As with all clinical studies, your participation is completely voluntary and you may choose to leave the study at any time.
I’m interested in hearing more. What is the next step?
To learn more about the study, give us a call at 503-245-1525, Monday through Thursday, during normal business hours, or Sign Up Today and we will give you a call to provide additional information.